| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.61 | 9e-07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |